Common Names
- Sha Shen Mai Dong Tang
- Sha Shen Mai Dong decoction
- Glehnia and Ophiopogon Decoction
- Bakumondoto (TJ-29)
For Patients & Caregivers
Tell your healthcare providers about any dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.
Sha Shen Mai Men Dong Tang (SMT) is a traditional Chinese medicine (TCM) formula. It’s made up of seven different herbs.
Sha Shen Mai Men Dong Tang is used to treat:
- Dry cough
- Dry mouth
Talk with your healthcare providers before taking herbal formulas. They can interact with some medications and affect how they work. For more information, read the “What else do I need to know?” section below.
Side effects have not been reported.
For Healthcare Professionals
Sha Shen Mai Men Dong Tang (SMT) is a traditional Chinese medicine formula documented in the classic text Wen Bing Tiao Bian. Historically used to relieve dry cough and dry mouth, it consists of seven different herbs: Glehnia littoralis (Sha Shen or Bei Sha Shen), Ophiopogon japonicus (Mai Dong or Mai Men Dong), Polygonatum odorati (Yu Zhu), Mulberry leaf (Sang Ye), Trichosanthes root (Tian Hua Fen), Hyacinth bean (Bian Dou or Sheng Bian Dou), and licorice (Gan Cao).
Limited clinical data suggest SMT helps manage symptoms in lung cancer patients with cachexia (1) and in pediatric patients with mycoplasma pneumonia (2). Its use has also been associated with improvements in inflammatory and cardiac biomarkers in patients with COVID-19 (3).
Additionally, Sha Shen Mai Dong Gan Lu Yin, a modified SMT formula, was reported useful in controlling symptoms of primary Sjögren’s syndrome (8).
Future trials with large sample sizes and robust methodology are needed to confirm the therapeutic potential of SMT.
- Dry cough
- Dry mouth
Pharmacological studies revealed several bioactive components in SMT including quercetin, kaempferol, β-sitosterol, and steroidal saponins, with known immunomodulatory and anti-inflammatory properties (4) (6).
In murine models, SMT was shown to downregulate the Notch pathway and decrease terminally differentiated CD8 T-cells, resulting in improved inflammatory profiles and enhanced effector function in T-cells (9). This formula also affected significant reductions in serum levels of interleukins IL-6, IL-1β, and tumor necrosis factor TNF-α in models of bronchitis, lung cancer and pulmonary fibrosis (6) (7) (13).
Potential mechanisms underlying SMT’s effects on Sjogren’s syndrome include regulation of Ras and cAMP-related signaling pathways; and immune function via its effects on macrophage differentiation, Toll-like receptor 4 signaling pathway and T-helper 1 cells (5).
Adverse reactions have not been reported.
None known.